OPK Stock OPK is expected to report earnings to fall -5.56% to -9 cents per share on May 07

A.I.dvisor
at Tickeron.com
05/06/24
Loading...
OPK - OPKO Health
OPKO Health Earnings Graph
Q1'24
Est.
$-0.09
Q4'23
Beat
by $0.01
Q3'23
Missed
by $0.01
Q2'23
Beat
by $0.04
Q1'23
Beat
by $0.07
The last earnings report on December 31 showed earnings per share of -9 cents, beating the estimate of -10 cents. P/B Ratio (0.662) is normal, around the industry mean (22.483). P/E Ratio (26.110) is within average values for comparable stocks, (82.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.589). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.149) is also within normal values, averaging (51.692). With 4.49M shares outstanding, the current market capitalization sits at 920.03M.
View a ticker or compare two or three
OPKDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4400 Biscayne Boulevard
Phone
+1 305 575-4100
Employees
3930
Web
https://www.opko.com